{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T18:34:18Z","timestamp":1792089258721,"version":"4.4.0"},"reference-count":46,"publisher":"Deutscher Arzte-Verlag GmbH","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"DOI":"10.3238\/arztebl.2013.0085","type":"journal-article","created":{"date-parts":[[2018,5,2]],"date-time":"2018-05-02T05:25:18Z","timestamp":1525238718000},"source":"Crossref","is-referenced-by-count":51,"title":["The Etiology, Diagnosis and Prevention of Liver Cirrhosis"],"prefix":"10.3238","author":[{"given":"Johannes","family":"Wiegand","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas","family":"Berg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"11437","published-online":{"date-parts":[[2013,2,8]]},"reference":[{"key":"10.3238\/arztebl.2013.0085_ref1","doi-asserted-by":"crossref","unstructured":"Manns MP, Czaja AJ, Gorham JD, et al.: Diagnosis and management of autoimmune hepatitis. Hepatology 2010; 51: 2193\u2013213.","DOI":"10.1002\/hep.23584"},{"key":"10.3238\/arztebl.2013.0085_ref2","doi-asserted-by":"crossref","unstructured":"Chen CF, Lee WC, Yang HI, et al.: Changes in serum levels of HBV DNA and alanine aminotransferase determine risk for hepatocellular carcinoma. Gastroenterology 2011; 141: 1240\u20138.","DOI":"10.1053\/j.gastro.2011.06.036"},{"key":"10.3238\/arztebl.2013.0085_ref3","unstructured":"Statistisches Bundesamt. Todesursachenstatistik. Gesundheitsberichterstattung des Bundes 2011."},{"key":"10.3238\/arztebl.2013.0085_ref4","doi-asserted-by":"crossref","unstructured":"Neuschwander-Tetri BA, Caldwell SH: Nonalcoholic steatohepatitis: summary of an AASLD Single Topic Conference. Hepatology 2003; 37: 1202\u201319.","DOI":"10.1053\/jhep.2003.50193"},{"key":"10.3238\/arztebl.2013.0085_ref5","unstructured":"Robert-Koch-Institut: Virushepatitis B, C und D im Jahr 2010. Epid Bull 2011; 29: 261\u201374."},{"key":"10.3238\/arztebl.2013.0085_ref6","doi-asserted-by":"crossref","unstructured":"Schuppan D, Afdhal NH: Liver cirrhosis. Lancet 2008; 371: 838\u201351.","DOI":"10.1016\/S0140-6736(08)60383-9"},{"key":"10.3238\/arztebl.2013.0085_ref7","doi-asserted-by":"crossref","unstructured":"Berg T: Diagnostik bei erh\u00f6hten Leberwerten. Der Gastroenterologe 2009; 4: 557\u201372.","DOI":"10.1007\/s11377-009-0340-0"},{"key":"10.3238\/arztebl.2013.0085_ref8","doi-asserted-by":"crossref","unstructured":"Tannapfel A, Dienes HP, Lohse AW: The indications for liver biopsy. Dtsch Arztebl Int 2012; 109(27\u201328): 477\u201383.","DOI":"10.3238\/arztebl.2012.0477"},{"key":"10.3238\/arztebl.2013.0085_ref9","doi-asserted-by":"crossref","unstructured":"Schirmacher P, Fleig WE, Tannapfel A, et al.: Bioptic diagnosis of chronic hepatitis. Results of an evidence-based consensus conference of the German Society of Pathology, of the German Society for Digestive and Metabolic Diseases and of Compensated Hepatitis (HepNet). Pathologe 2004; 25: 337\u201348.","DOI":"10.1007\/s00292-004-0692-7"},{"key":"10.3238\/arztebl.2013.0085_ref10","doi-asserted-by":"crossref","unstructured":"Castera L, Pinzani M: Biopsy and non-invasive methods for the diagnosis of liver fibrosis: does it take two to tango? Gut 2010; 59: 861\u20136.","DOI":"10.1136\/gut.2010.214650"},{"key":"10.3238\/arztebl.2013.0085_ref11","doi-asserted-by":"crossref","unstructured":"Wai CT, Greenson JK, Fontana RJ, et al.: A simple noninvasive index can predict both significant fibrosis and cirrhosis in patients with chronic hepatitis C. Hepatology 2003; 38: 518\u201326.","DOI":"10.1053\/jhep.2003.50346"},{"key":"10.3238\/arztebl.2013.0085_ref12","doi-asserted-by":"crossref","unstructured":"Forns X, Ampurdanes S, Llovet JM, et al.: Identification of chronic hepatitis C patients without hepatic fibrosis by a simple predictive model. Hepatology 2002; 36: 986\u201392.","DOI":"10.1016\/S0270-9139(02)00107-6"},{"key":"10.3238\/arztebl.2013.0085_ref13","doi-asserted-by":"crossref","unstructured":"Vallet-Pichard A, Mallet V, Nalpas B, et al.: FIB-4: an inexpensive and accurate marker of fibrosis in HCV infection. comparison with liver biopsy and fibrotest. Hepatology 2007; 46: 32\u20136.","DOI":"10.1002\/hep.21669"},{"key":"10.3238\/arztebl.2013.0085_ref14","doi-asserted-by":"crossref","unstructured":"Imbert-Bismut F, Ratziu V, Pieroni L, Charlotte F, Benhamou Y, Poynard T: Biochemical markers of liver fibrosis in patients with hepatitis C virus infection: a prospective study. Lancet 2001; 357: 1069\u201375.","DOI":"10.1016\/S0140-6736(00)04258-6"},{"key":"10.3238\/arztebl.2013.0085_ref15","doi-asserted-by":"crossref","unstructured":"Poynard T, Halfon P, Castera L, et al.: Standardization of ROC curve areas for diagnostic evaluation of liver fibrosis markers based on prevalences of fibrosis stages. Clin Chem 2007; 53: 1615\u201322.","DOI":"10.1373\/clinchem.2007.085795"},{"key":"10.3238\/arztebl.2013.0085_ref16","doi-asserted-by":"crossref","unstructured":"Rosenberg WM, Voelker M, Thiel R, et al.: Serum markers detect the presence of liver fibrosis: a cohort study. Gastroenterology 2004; 127: 1704\u201313.","DOI":"10.1053\/j.gastro.2004.08.052"},{"key":"10.3238\/arztebl.2013.0085_ref17","doi-asserted-by":"crossref","unstructured":"Snyder N, Gajula L, Xiao SY, et al.: APRI: an easy and validated predictor of hepatic fibrosis in chronic hepatitis C. J Clin Gastroenterol 2006; 40: 535\u201342.","DOI":"10.1097\/00004836-200607000-00013"},{"key":"10.3238\/arztebl.2013.0085_ref18","doi-asserted-by":"crossref","unstructured":"Friedrich-Rust M, Ong MF, Martens S, et al.: Performance of transient elastography for the staging of liver fibrosis: a meta-analysis. Gastroenterology 2008; 134: 960\u201374.","DOI":"10.1053\/j.gastro.2008.01.034"},{"key":"10.3238\/arztebl.2013.0085_ref19","doi-asserted-by":"crossref","unstructured":"Friedrich-Rust M, Nierhoff J, Lupsor M, et al.: Performance of Acoustic Radiation Force Impulse imaging for the staging of liver fibrosis: a pooled meta-analysis. J Viral Hepat 2012; 19: e212\u2013e219.","DOI":"10.1111\/j.1365-2893.2011.01537.x"},{"key":"10.3238\/arztebl.2013.0085_ref20","doi-asserted-by":"crossref","unstructured":"Sebastiani G, Castera L, Halfon P, et al.: The impact of liver disease aetiology and the stages of hepatic fibrosis on the performance of non-invasive fibrosis biomarkers: an international study of 2411 cases. Aliment Pharmacol Ther 2011; 34: 1202\u201316.","DOI":"10.1111\/j.1365-2036.2011.04861.x"},{"key":"10.3238\/arztebl.2013.0085_ref21","doi-asserted-by":"crossref","unstructured":"Argo CK, Northup PG, Al-Osaimi AM, Caldwell SH: Systematic review of risk factors for fibrosis progression in non-alcoholic steatohepatitis. J Hepatol 2009; 51: 371\u20139.","DOI":"10.1016\/j.jhep.2009.03.019"},{"key":"10.3238\/arztebl.2013.0085_ref22","doi-asserted-by":"crossref","unstructured":"Romeo S, Kozlitina J, Xing C, et al.: Genetic variation in PNPLA3 confers susceptibility to nonalcoholic fatty liver disease. Nat Genet 2008; 40: 1461\u20135.","DOI":"10.1038\/ng.257"},{"key":"10.3238\/arztebl.2013.0085_ref23","doi-asserted-by":"crossref","unstructured":"Stickel F, Buch S, Lau K, et al.: Genetic variation in the PNPLA3 gene is associated with alcoholic liver injury in caucasians. Hepatology 2011; 53: 86\u201395.","DOI":"10.1002\/hep.24017"},{"key":"10.3238\/arztebl.2013.0085_ref24","doi-asserted-by":"crossref","unstructured":"Sarrazin C, Berg T, Ross RS, et al.: Prophylaxis, diagnosis and therapy of hepatitis C virus (HCV) infection: the German guidelines on the management of HCV infection. Z Gastroenterol 2010; 48: 289\u2013351.","DOI":"10.1055\/s-0028-1110008"},{"key":"10.3238\/arztebl.2013.0085_ref25","doi-asserted-by":"crossref","unstructured":"Cornberg M, Protzer U, Petersen J, et al.: Prophylaxis, diagnosis and therapy of hepatitis B virus infection \u2013 the German guideline. Z Gastroenterol 2011; 49: 871\u2013930.","DOI":"10.1055\/s-0031-1273462"},{"key":"10.3238\/arztebl.2013.0085_ref26","doi-asserted-by":"crossref","unstructured":"European Association For The Study Of The Liver: EASL Clinical Practice Guidelines: Management of chronic hepatitis B virus infection. J Hepatol 2012; 57: 167\u201385.","DOI":"10.1016\/j.jhep.2012.02.010"},{"key":"10.3238\/arztebl.2013.0085_ref27","doi-asserted-by":"crossref","unstructured":"Wedemeyer H, Hofmann WP, Lueth S, et al.: ALT screening for chronic liver diseases: scrutinizing the evidence. Z Gastroenterol 2010; 48: 46\u201355.","DOI":"10.1055\/s-0028-1109980"},{"key":"10.3238\/arztebl.2013.0085_ref28","doi-asserted-by":"crossref","unstructured":"Breitling LP, Claessen H, Drath C, Arndt V, Brenner H: Gamma-glutamyltransferase, general and cause-specific mortality in 19,000 construction workers followed over 20 years. J Hepatol 2011; 55: 594\u2013601.","DOI":"10.1016\/j.jhep.2010.12.029"},{"key":"10.3238\/arztebl.2013.0085_ref29","doi-asserted-by":"crossref","unstructured":"Claessen H, Brenner H, Drath C, Arndt V: Gamma-glutamyltransferase and disability pension: a cohort study of construction workers in Germany. Hepatology 2010; 51: 482\u201390.","DOI":"10.1002\/hep.23324"},{"key":"10.3238\/arztebl.2013.0085_ref30","doi-asserted-by":"crossref","unstructured":"Haring R, Wallaschofski H, Nauck M, Dorr M, Baumeister SE, Volzke H: Ultrasonographic hepatic steatosis increases prediction of mortality risk from elevated serum gamma-glutamyl transpeptidase levels. Hepatology 2009; 50: 1403\u201311.","DOI":"10.1002\/hep.23135"},{"key":"10.3238\/arztebl.2013.0085_ref31","doi-asserted-by":"crossref","unstructured":"Roulot D, Costes JL, Buyck JF, et al.: Transient elastography as a screening tool for liver fibrosis and cirrhosis in a community-based population aged over 45 years. Gut 2011; 60: 977\u201384.","DOI":"10.1136\/gut.2010.221382"},{"key":"10.3238\/arztebl.2013.0085_ref32","doi-asserted-by":"crossref","unstructured":"Bell BP, Manos MM, Zaman A, et al.: The epidemiology of newly diagnosed chronic liver disease in gastroenterology practices in the United States: results from population-based surveillance. Am J Gastroenterol 2008; 103: 2727\u201336.","DOI":"10.1111\/j.1572-0241.2008.02071.x"},{"key":"10.3238\/arztebl.2013.0085_ref33","doi-asserted-by":"crossref","unstructured":"Hofmann WP, Sarrazin C, Zeuzem S: Current standards in the treatment of chronic hepatitis C. Dtsch Arztebl Int 2012; 109(19): 352\u20138.","DOI":"10.3238\/arztebl.2012.0352"},{"key":"10.3238\/arztebl.2013.0085_ref34","doi-asserted-by":"crossref","unstructured":"EASL clinical practice guidelines for HFE hemochromatosis: J Hepatol 2010; 53: 3\u201322.","DOI":"10.1016\/j.jhep.2010.03.001"},{"key":"10.3238\/arztebl.2013.0085_ref35","doi-asserted-by":"crossref","unstructured":"EASL Clinical Practice Guidelines: Wilson's disease. J Hepatol 2012; 56: 671\u201385.","DOI":"10.1016\/j.jhep.2011.11.007"},{"key":"10.3238\/arztebl.2013.0085_ref36","doi-asserted-by":"crossref","unstructured":"O'Shea RS, Dasarathy S, McCullough AJ: Alcoholic liver disease. Hepatology 2010; 51: 307\u201328.","DOI":"10.1002\/hep.23258"},{"key":"10.3238\/arztebl.2013.0085_ref37","doi-asserted-by":"crossref","unstructured":"Wittenburg H, Tennert U, Berg T: Complications of liver cirrhosis. Internist 2011; 52: 1061\u201370.","DOI":"10.1007\/s00108-011-2853-0"},{"key":"10.3238\/arztebl.2013.0085_ref38","doi-asserted-by":"crossref","unstructured":"Eckman MH, Kaiser TE, Sherman KE: The cost-effectiveness of screening for chronic hepatitis B infection in the United States. Clin Infect Dis 2011; 52: 1294\u2013306.","DOI":"10.1093\/cid\/cir199"},{"key":"10.3238\/arztebl.2013.0085_ref39","doi-asserted-by":"crossref","unstructured":"Zein CO, Unalp A, Colvin R, Liu YC, McCullough AJ: Smoking and severity of hepatic fibrosis in nonalcoholic fatty liver disease. J Hepatol 2011; 54: 753\u20139.","DOI":"10.1016\/j.jhep.2010.07.040"},{"key":"10.3238\/arztebl.2013.0085_ref40","doi-asserted-by":"crossref","unstructured":"Modi AA, Feld JJ, Park Y, et al.: Increased caffeine consumption is associated with reduced hepatic fibrosis. Hepatology 2010; 51: 201\u20139.","DOI":"10.1002\/hep.23279"},{"key":"10.3238\/arztebl.2013.0085_ref41","unstructured":"European Liver Transplant Registry. 2012."},{"key":"10.3238\/arztebl.2013.0085_ref42","doi-asserted-by":"crossref","unstructured":"Lackner C, Struber G, Bankuti C, Bauer B, Stauber RE: Noninvasive diagnosis of cirrhosis in chronic hepatitis C based on standard laboratory tests. Hepatology 2006; 43: 378\u20139.","DOI":"10.1002\/hep.21037"},{"key":"10.3238\/arztebl.2013.0085_ref43","doi-asserted-by":"crossref","unstructured":"Sofair AN, Barry V, Manos MM, et al.: The epidemiology and clinical characteristics of patients with newly diagnosed alcohol-related liver disease: results from population-based surveillance. J Clin Gastroenterol 2010; 44: 301\u20137.","DOI":"10.1097\/MCG.0b013e3181b3f760"},{"key":"10.3238\/arztebl.2013.0085_ref44","doi-asserted-by":"crossref","unstructured":"Julapalli VR, Kramer JR, El-Serag HB: Evaluation for liver transplantation: adherence to AASLD referral guidelines in a large Veterans Affairs center. Liver Transpl 2005; 11: 1370\u20138.","DOI":"10.1002\/lt.20434"},{"key":"10.3238\/arztebl.2013.0085_ref45","doi-asserted-by":"crossref","unstructured":"Sanyal A, Poklepovic A, Moyneur E, Barghout V: Population-based risk factors and resource utilization for HCC: US perspective. Curr Med Res Opin 2010; 26: 2183\u201391.","DOI":"10.1185\/03007995.2010.506375"},{"key":"10.3238\/arztebl.2013.0085_ref46","unstructured":"Marcellin P, Buti M, Gane E, et al.: Five years of treatment with tenofovir DF (TDF) for chronic hepatitis B (CHB) infection is associated with sustained viral suppression and significant regression of histological fibrosis and cirrhosis. Hepatology 2011; 54: 1011A."}],"container-title":["Deutsches \u00c4rzteblatt international"],"original-title":[],"link":[{"URL":"https:\/\/www.aerzteblatt.de\/10.3238\/arztebl.2013.0085","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,12,6]],"date-time":"2021-12-06T08:26:11Z","timestamp":1638779171000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.aerzteblatt.de\/10.3238\/arztebl.2013.0085"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,2,8]]},"references-count":46,"URL":"https:\/\/doi.org\/10.3238\/arztebl.2013.0085","relation":{"is-cited-by":[{"id-type":"doi","id":"10.4254\/wjh.v7.i4.662","asserted-by":"object"},{"id-type":"doi","id":"10.12688\/f1000research.11938.1","asserted-by":"object"},{"id-type":"doi","id":"10.3748\/wjg.v22.i1.72","asserted-by":"object"}]},"ISSN":["1866-0452"],"issn-type":[{"value":"1866-0452","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,2,8]]}}}